Coronavirus Notebook: Janssen Vaccine Approved In GB, Comirnaty Cleared in EU for 12-15 Year Olds
With the spread of virus variants causing growing concern, the World Health Organization has come up with a user-friendly variant naming scheme that will simplify reporting and help avoid the stigma attached to naming new strains after the place they were first detected.
You may also be interested in...
Thirteen of the 20 new active substances that were approved in the EU between January and April this year have also now received regulatory clearance in Great Britain, Pink Sheet analysis finds. New filing procedures have been in place there since 1 January.
Without giving ACIP a chance to vote on the change or providing additional data, CDC announces new guidance allowing coadministration of COVID-19 vaccines with other immunizations. Needless to say, the decision raised a few eyebrows.
As discussions continue over the European Commission’s plans to overhaul the EU pharmaceutical legislation, the R&D-based pharma industry body EFPIA says that any new pharma policy framework will need to be stable, fast, effective and globally competitive.